Appointment of Nominated Adviser and Joint Broker

Source: RNS
RNS Number : 7921L
Mortgage Advice Bureau (Hldgs) PLC
12 November 2024
 

12 November 2024

 

Mortgage Advice Bureau (Holdings) plc

("MAB" or the "Company")

 

Appointment of Nominated Adviser and Joint Broker

 

Mortgage Advice Bureau (Holdings) plc (AIM: MAB1.L), one of the UK's leading networks for mortgage intermediaries, announces that Keefe, Bruyette & Woods, a Stifel Company has been appointed as the Company's Nominated Adviser and joint broker with immediate effect.

 

 

 

Enquiries:

 

Mortgage Advice Bureau (Holdings) plc   

Via Camarco

 

Peter Brodnicki, Chief Executive Officer

Ben Thompson, Deputy Chief Executive Officer

Emilie McCarthy, Chief Financial Officer

 



Nominated Adviser and Joint Broker

Keefe, Bruyette & Woods, a Stifel Company

Alistair McKay / Erik Anderson / Nick Harland / Harry Billen

 

 

  +44 (0)20 7710 7600

Joint Broker

Peel Hunt LLP

Andrew Buchanan / Oliver Jackson

 

 

 

+44 (0) 20 7418 8900

Media Enquiries

Camarco

Tom Huddart / Louise Dolan / Letaba Rimell

 

 

mab@camarco.co.uk

Investor Relations

 

Investor.relations@mab.org.uk



About Mortgage Advice Bureau:

 

MAB is one of the UK's leading consumer intermediary brands and specialist networks for mortgage advisers. 

 

Through its partner firms known as Appointed Representatives ("ARs") MAB has approximately 2,000 advisers providing expert advice to customers on a range of mortgage, protection, and general insurance products. MAB supports its AR firms with proprietary technology and services, including adviser recruitment and lead generation, learning and development, compliance auditing and supervision, and digital marketing and website solutions.

 

MAB is listed on the London Stock Exchange (AIM:MAB1.L). For more information, visit www.mortgageadvicebureau.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPEANFFFDELFFA